Funding for this research was provided by:
Siemens Healthcare USA
Received: 25 April 2019
Accepted: 2 July 2019
First Online: 31 July 2019
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Review Board at the Medical University of South Carolina and complied with the HIPAA guidelines.
: All patients provided written informed consent.
: U. Joseph Schoepf is a consultant for and/or receives research support from Astellas, Bayer, Elucid Bioimaging, GE, Guerbet, HeartFlow Inc., and Siemens. Davide Piccini is an employee of Siemens. John Heerfordt’s doctoral studies are financially supported by Siemens. Akos Varga-Szemes receives institutional research support and travel support from Siemens and is a consultant for Elucid Bioimaging. The other authors declare that they have no competing interests.